Latest revenue
$114.5M
as of 2026-03-31
Latest net income
$45.3M
as of 2026-03-31
Net margin
39.6%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $1.91B
- Enterprise value
- $1.91B
- P/E (trailing)
- 13.0×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $22.37
- 52-wk low
- $7.21
- Beta
- —
- Shares out
- 231.8M
5-year trend
About ADMA
Business description and risk factors will appear here once ADMA's latest filing is fully ingested.
Profitability
Gross margin
57.4%
11.5%Operating margin
37.5%
15.1%Net margin
28.8%
37.9%Return on equity
30.8%
45.6%Return on assets
23.5%
41.8%Leverage
Debt / equity
0.31×
23.1%Long-term debt / equity
0.15×
29.9%Debt / assets
23.5%
17.6%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $114.5M | -0.3% | $45.3M | +68.5% | 39.6% |
Q4 2025 2025-12-31 | $139.2M | +18.4% | $49.4M | -55.9% | 35.5% |
Q3 2025 2025-09-30 | $134.2M | +12.0% | $36.4M | +1.4% | 27.1% |
Q2 2025 2025-06-30 | $122.0M | +13.8% | $34.2M | +6.7% | 28.1% |
Q1 2025 2025-03-31 | $114.8M | +40.2% | $26.9M | +51.1% | 23.4% |
Q4 2024 2024-12-31 | $117.5M | — | $111.9M | — | 95.2% |
Q3 2024 2024-09-30 | $119.8M | +78.1% | $35.9M | +1300.0% | 30.0% |
Q2 2024 2024-06-30 | $107.2M | +78.3% | $32.1M | +603.3% | 29.9% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Biological Products, (No Diagnostic Substances) · SIC 2836
Your notes
Keep private notes on ADMA — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$417.7K
Insider selling
$12.9M
Net activity
−$12.5M
Distinct insiders
5
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ADMA
Institutional value
$1.03B
Total shares held
115.4M
Distinct holders
214
-140 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 36.8M | $331.8M | +497.4K (+1.4%) | Added |
| 2 | Capital Research Global Investors | 11.2M | $100.8M | +4.6M (+68.6%) | Added |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 10.3M | $92.9M | — | New |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.9M | $79.9M | — | New |
| 5 | Nuveen, LLC | 6.1M | $54.9M | +171.8K (+2.9%) | Added |
| 6 | DIMENSIONAL FUND ADVISORS LP | 5.0M | $45.1M | +169.8K (+3.5%) | Added |
| 7 | Invesco Ltd. | 4.1M | $37.1M | -7.7M (-65.0%) | Trimmed |
| 8 | JANE STREET GROUP, LLC | 3.1M | $27.5M | +2.6M (+564.3%) | Added |
| 9 | FRANKLIN RESOURCES INC | 2.3M | $21.1M | -449.0K (-16.1%) | Trimmed |
| 10 | UBS Group AG | 2.2M | $19.4M | -2.4M (-52.9%) | Trimmed |
| 11 | BNP PARIBAS FINANCIAL MARKETS | 1.9M | $17.2M | +764.4K (+67.0%) | Added |
| 12 | FEDERATED HERMES, INC. | 1.7M | $15.3M | +1.5M (+797.0%) | Added |
| 13 | VANGUARD FIDUCIARY TRUST CO | 1.6M | $14.8M | — | New |
| 14 | PRINCIPAL FINANCIAL GROUP INC | 1.4M | $12.5M | -13.0K (-0.9%) | Trimmed |
| 15 | Bank of New York Mellon Corp | 1.4M | $12.2M | -47.8K (-3.4%) | Trimmed |
| 16 | Y-Intercept (Hong Kong) Ltd | 1.1M | $9.7M | +1.0M (+1508.1%) | Added |
| 17 | DEUTSCHE BANK AG\ | 931.0K | $8.4M | -892.0K (-48.9%) | Trimmed |
| 18 | Public Sector Pension Investment Board | 851.4K | $7.7M | +27.7K (+3.4%) | Added |
| 19 | Russell Investments Group, Ltd. | 711.7K | $6.4M | -344.6K (-32.6%) | Trimmed |
| 20 | JUPITER ASSET MANAGEMENT LTD | 711.5K | $6.4M | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once ADMA's latest filing finishes processing.